The Gut-Liver Axis in Multiple Organ Failure

  • J. C. Marshall
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 16)


Advances in the management of acute life-threatening illness have resulted in progressively improving rates of survival for a broad spectrum of disorders. These same advances, directed against the immediate threat to survival posed, for example, by bleeding, infection, or acute organ system failure, have profoundly altered patterns of morbidity and mortality in critical illness. In the wake of increasing success in the management of acute physiological instability has arisen a new series of clinical challenges: those that result not from the original injury but from the host response to injury, and from the therapeutic measures taken to achieve short term survival.


Alveolar Macrophage Kupffer Cell Multiple Organ Failure Bacterial Translocation Frog Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Marshall JC (1991) Multiorgan Failure. In: Wilmore DW, Brennan MF, Harken AH, Holcroft JW, Meakins JL (eds) Care of the Surgical Patient. Volume I Critical Care. Scientific American, New York, pp 1–20Google Scholar
  2. 2.
    Chen TSN, Chen PSY (1989) Intestinal autointoxication: a medical leitmotif. J Clin Gastro-enterol 11:434–441CrossRefGoogle Scholar
  3. 3.
    Majno G (1991) The ancient riddle of sepsis. J Infect Dis 163:937–945PubMedCrossRefGoogle Scholar
  4. 4.
    Metchnikoff E (1905) The Nature of Man. Studies in Optimistic Philosophy. GP. Putnam’s Sons, New York and LondonGoogle Scholar
  5. 5.
    Lane WA (1912) A clinical lecture on chronic intestinal stasis. BMJ 1:989–993PubMedCrossRefGoogle Scholar
  6. 6.
    Schweinburg FB, Seligman AM, Fine J (1950) Transmural migration of intestinal bacteria. A study based on the use of radioactive Escherichia coli. N Engl J Med 242:747–751PubMedCrossRefGoogle Scholar
  7. 7.
    Lillehei RC (1957) The intestinal factor in irreversible hemorrhagic shock. Surgery 42:1043–1054PubMedGoogle Scholar
  8. 8.
    Fine J, Frank ED, Ravin HA, Rutenberg SH, Schweinburg FB (1959) The bacterial factor in traumatic shock. N Engl J Med 260:214–220PubMedCrossRefGoogle Scholar
  9. 9.
    Schweinburg FB, Fine J (1960) Evidence for lethal endotoxemia as the fundamental feature of irreversibility in three types of traumatic shock. J Exp Med 112:793–800PubMedCrossRefGoogle Scholar
  10. 10.
    Evans WE, Darin JC (1966) Effect of enterectomy in endotoxin shock. Surgery 60:1026–1029PubMedGoogle Scholar
  11. 11.
    Garrison RN, Fry DE, Berberich S, Polk HC (1982) Enterococcal bacteremia. Clinical implications and determinants of death. Ann Surg 196:43–47PubMedCrossRefGoogle Scholar
  12. 12.
    Dyess DL, Garrison RN, Fry DE (1985) Candida sepsis. Implications of polymicrobial blood-borne infection. Arch Surg 120:345–348PubMedCrossRefGoogle Scholar
  13. 13.
    Marshall JC, Christou NV, Horn H, Meakins JL (1988) The microbiology of multiple organ failure. The proximal GI tract as an occult reservoir of pathogens. Arch Surg 123:309–315PubMedCrossRefGoogle Scholar
  14. 14.
    Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR (1986) Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 133:792–796PubMedGoogle Scholar
  15. 15.
    Marshall J, Sweeney D (1990) Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome. Arch Surg 125:17–23PubMedCrossRefGoogle Scholar
  16. 16.
    Polk HC, Shields CL (1977) Remote organ failure: A valid sign of occult intra-abdominal infection. Surgery 81:310–313PubMedGoogle Scholar
  17. 17.
    Norton LW (1985) Does drainage of intra-abdominal pus reverse multiple organ failure? Am J Surg 149:347–350PubMedCrossRefGoogle Scholar
  18. 18.
    Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV (1986) Multiple-organ-failure-syndrome. The GI tract: The “motor” of MOF. Arch Surg 121:196–208PubMedCrossRefGoogle Scholar
  19. 19.
    Border JR, Hassett J, LaDuca J, et al. (1987) The gut origin septic states in blunt multiple trauma (ISS=40) in the ICU. Ann Surg 206:427–448PubMedCrossRefGoogle Scholar
  20. 20.
    Wilmore DW, Smith RJ, O’Dwyer ST, Jacobs DO, Ziegler TR, Wang XD (1988) The gut: A central organ after surgical stress. Surgery 104:917–923PubMedGoogle Scholar
  21. 21.
    Deitch EA (1988) Does the gut protect us or injure us when ill in the ICU? In: Cerra F (ed) Perspectives in Critical Care, Quality Medical, St. Louis pp 1–32Google Scholar
  22. 22.
    Drasar BS, Shiner M, McLeod GM (1969) Studies on the intestinal flora. I. The bacterial flora of the gastronintestinal tract in healthy and achlorhydric persons. Gastroenterology 56:71–79PubMedGoogle Scholar
  23. 23.
    Stockbrugger RW, Cotton PB, Eugenides N, Bartholomew BA, Hill MJ, Walters CL (1982) Intragastric nitrates, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut 23:1048–1054PubMedCrossRefGoogle Scholar
  24. 24.
    Greenlee HB, Vivit R, Paez J, Dietz A (1971) Bacterial flora of the jejunum following peptic ulcer surgery. Arch Surg 102:260–265PubMedCrossRefGoogle Scholar
  25. 25.
    Gianella RA, Broitman SA, Zamcheck N (1972) Gastric acid barrier to ingested microorganisms in man: Studies in vivo and in vitro. Gut 13:251–256CrossRefGoogle Scholar
  26. 26.
    Martini GA, Phear EA, Ruebner B, Sherlock S (1957) The bacterial content of the small inte-stine in normal and cirrhotic subjects: Relation to methionine toxicity. Clin Sci 16:35–51PubMedGoogle Scholar
  27. 27.
    Bode JC, Bode C, Heidelbach R, Durr HK, Martini GA (1984) Jejunal microflora in patients with chronic alcohol abuse. Hepato-gastroenterol 31:30–34Google Scholar
  28. 28.
    Garvey BM, McCambley JA, Tuxen DV (1989) Effects of gastric alkalization on bacterial colonization in critically ill patients. Crit Care Med 17:211–216PubMedCrossRefGoogle Scholar
  29. 29.
    Marshall JC (1991) The ecology and immunology of the gastrointestinal tract in health and critical illness. J Hosp Infect 19(Suppl C):7–17PubMedCrossRefGoogle Scholar
  30. 30.
    de Moulin GC, Hedley-White J, Paterson DG, Lisbon A (1982) Aspiration of gastric bacteria in antacid-treated patients: A frequent cause of postoperative colonisation of the airway. Lancet 1:242–244PubMedGoogle Scholar
  31. 31.
    Driks MR, Craven DE, Celli BR, et al (1987) Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med 317:1376–1382PubMedCrossRefGoogle Scholar
  32. 32.
    Marshall JC, Christou NV, Meakins JL (1988) Small bowel bacterial overgrowth and systemic immunosuppression in experimental peritonitis. Surgery 104:404–411PubMedGoogle Scholar
  33. 33.
    Deitch EA, Sittig K, Li M, Berg RD, Specian D (1990) Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 159:79–84PubMedCrossRefGoogle Scholar
  34. 34.
    Kennedy MJ, Volz PA (1985) Ecology of Candida albicans gut colonization: Inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immun 49:654–663PubMedGoogle Scholar
  35. 35.
    Hentges DJ, Stein AJ, Casey SW, Que JU (1985) Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: Influence of antibiotics on colonization resistance. Infect Immun 47:118–122PubMedGoogle Scholar
  36. 36.
    Marshall JC, Christou NV, de Santis M, Meakins JL (1987) Proximal gastrointestinal flora and systemic infection in the critically ill surgical patient. Surg Forum 38:89–91Google Scholar
  37. 37.
    Abrams GD (1988) Impact of the intestinal microflora on intestinal structure and function. In: Hentges DJ (ed) Human Intestinal Microflora in Health and Disease, Academic Press Inc, New York, pp 292–310Google Scholar
  38. 38.
    Ohwaki M, Yasutake N, Yasui H, Ogura R (1977) A comparative study on the humoral immune responses in germfree and conventional mice. Immunology 32:43–48PubMedGoogle Scholar
  39. 39.
    MacDonald TT, Carter PB (1979) Requirements for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells. J Immunol 122:2624–2629PubMedGoogle Scholar
  40. 40.
    Abrams GD, Bishop JE (1965) Normal flora and leukocyte mobilization. Arch Pathol 79:213–217PubMedGoogle Scholar
  41. 41.
    Morland B, Smievoll AI, Midtvedt T (1979) Comparison of peritoneal macrophages from germfree and conventional mice. Infect Immun 26:1129–1136PubMedGoogle Scholar
  42. 42.
    Dubos RJ, Schaedler RW (1960) The effect of the intestinal flora on the growth rate of mice and on their susceptibility to experimental infections. J Exp Med 111:407–417PubMedCrossRefGoogle Scholar
  43. 43.
    Mattingly JA, Eardley DD, Kemp JD, Gershon K (1979) Induction of suppressor cells in rat spleen: Influence of microbial stimulation. J Immunol 122:787–790PubMedGoogle Scholar
  44. 44.
    Rutenburg AM, Sonnenblick E, Koven I, Aprahamian HA, Reiner L, Fine J (1957) The role of intestinal bacteria in the development of dietary cirrhosis in rats. J Exp Med 106:1–14PubMedCrossRefGoogle Scholar
  45. 45.
    Nolan JP, Leibowitz AI (1978) Endotoxin and the liver, in. Modification of acute carbon te-trachloride injury by polymyxin B-an antiendotoxin. Gastroenterology 75:445–449PubMedGoogle Scholar
  46. 46.
    Gut JP, Schmitt S, Bingen A, Anton M, Kirn A (1982) Protective effect of colectomy in frog virus 3 hepatitis of rats: Possible role of endotoxin. J Infect Dis 146:594–605PubMedCrossRefGoogle Scholar
  47. 47.
    Penhale WJ, Young PR (1988) The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis. Clin Exp Immunol 72:288–292PubMedGoogle Scholar
  48. 48.
    Midtvedt T (1987) Intestinal bacteria and rheumatic disease. Scand J Rheumatol 64(Suppl):49–54CrossRefGoogle Scholar
  49. 49.
    Severijnen AJ, van Kleef R, Hazenberg MP, van de Merwe JP (1990) Chronic arthritis induced in rats by cell wall fragments of Eubacterium species from the human intestinal flora. Infect Immun 58:523–528PubMedGoogle Scholar
  50. 50.
    Abraham E (1989) Host defense abnormalities after hemorrhage, trauma, and burns. Crit Care med 17:934–939PubMedCrossRefGoogle Scholar
  51. 51.
    Craven DE, Driks MR (1987) Nosocomial pneumonia in the intubated patient. Semin Resp Infect 2:20–33Google Scholar
  52. 52.
    Kingston GW, Phang PT, Leathley MJ (1991) Increased incidence of nosocomial pneumonia in mechanically ventilated patients with subclinical aspiration. Am J Surg 161:589–592PubMedCrossRefGoogle Scholar
  53. 53.
    Tabor DR, Burchett SK, Jacobs RF (1988) Enhanced production of monokines by canine alveolar macrophages in response to endotoxin-induced shock. Proc Soc Exp Biol Med 187:408–415PubMedGoogle Scholar
  54. 54.
    Becker S, Devlin RB, Haskill JS (1989) Differential production of tumor necrosis factor, macrophage colony stimulating factor, and interleukin-1 by human alveolar macrophages. J Leuk Biol 45:353–361Google Scholar
  55. 55.
    Callery MP, Kamei T, Mangino MJ, Flye MW (1991) Organ interactions in sepsis. Host defense and the hepatic pulmonary macrophage axis. Arch Surg 126:28–32PubMedCrossRefGoogle Scholar
  56. 56.
    Harmsen AG (1988) Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation. Infect Immun 56:1858–1863PubMedGoogle Scholar
  57. 57.
    Christman JW, Petras SF, Vacek PM, Davis GS (1989) Rat alveolar macrophage production of che-moattractants for neutrophils: response to Escherichia coli endotoxin. Infect Immun 57:810–816PubMedGoogle Scholar
  58. 58.
    Ferrari-Baliviera E, Mealy K, Smith RJ, Wilmore DW (1989) Tumor necrosis factor induces adult respiratory distress syndrome in rats. Arch Surg 124:1400–1405PubMedCrossRefGoogle Scholar
  59. 59.
    Mallick AA, Ishizaka A, Stephens KE, Hatherill JR, Tazelaar HD, Raffln TA (1989) Multiple organ damage caused by tumor necrosis factor and prevented by prior neutrophil depletion. Chest 95:1114–1120PubMedCrossRefGoogle Scholar
  60. 60.
    Twomey JJ, Laughter A, Brown MF (1983) A comparison of the regulatory effects of human monocytes, pulmonary alveolar macrophages (PAMs) and spleen macrophages upon lymphocyte responses. Clin Exp Immunol 52:449–454PubMedGoogle Scholar
  61. 61.
    Holt PG (1986) Downregulation of immune responses in the lower respiratory tract: The role of alveolar macrophages. Clin Exp Immunol 63:261–270PubMedGoogle Scholar
  62. 62.
    Berg RD (1981) Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronidazole. Infect Immun 33:854–861PubMedGoogle Scholar
  63. 63.
    Deitch EA, Winterton J, Li M, Berg R (1987) The gut as a portal of entry for bacteremia. Role of protein malnutrition. Ann Surg 205:681–692PubMedCrossRefGoogle Scholar
  64. 64.
    Wells CL, Rotstein OD, Pruett TL, Simmons RL (1986) Intestinal bacteria translocate into experimental intra-abdominal abscesses. Arch Surg 121:102–107PubMedCrossRefGoogle Scholar
  65. 65.
    Alexander JW, Gianotti L, Pyles T, Carey MA, Babcock GF (1991) Distribution and survival of Escherichia coli translocating from the intestine after thermal injury. Ann Surg 213:558–567PubMedCrossRefGoogle Scholar
  66. 66.
    Krause W, Matheis H, Wulf K (1969) Fungaemia and funguria after oral administration of Candida albicans. Lancet 1:598–599PubMedCrossRefGoogle Scholar
  67. 67.
    Gaussorgues PH, Gueugniaud PY, Vedrinne JM, Salord F, Mercatello A, Robert D (1986) Septicémies dans les suites immédiates des arrêts cardio-circulatoires. Réan Soins Intens Med Urg 2:67–69Google Scholar
  68. 68.
    Deitch EA (1989) Simple intestinal obstruction causes bacterial translocation in man. Arch Surg 124:699–701PubMedCrossRefGoogle Scholar
  69. 69.
    Wells CL, Maddaus MA, Simmons RL (1988) Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis 10:958–979PubMedCrossRefGoogle Scholar
  70. 70.
    Howerton EE, Kolmen N (1972) The intestinal tract as a portal of entry of Pseudomonas in burned rats. J Trauma 12:335–340PubMedCrossRefGoogle Scholar
  71. 71.
    LeFrock JL, Ellis CA, Turchik JB, Weinstein L (1973) Transient bacteremia associated with sigmoidoscopy. N Engl J Med 289:467–469CrossRefGoogle Scholar
  72. 72.
    Dickman MD, Farrell R, Higgs RH, Wright LE, Humphries TJ, Wojcik JD (1976) Colonos-copy associated bacteremia. Surg Gynecol Obstet 142:173–176PubMedGoogle Scholar
  73. 73.
    Deitch EA, Xu D, Qi L, Berg RD (1991) Bacterial translocation from the gut impairs systemic immunity. Surgery 109:269–276PubMedGoogle Scholar
  74. 74.
    Marshall JC, Christou NV, Meakins JL (1988) Small-bowel bacterial overgrowth and sy-stemic immunosuppression in experimental peritonitis. Surgery 104:404–411PubMedGoogle Scholar
  75. 75.
    Sullivan BJ, Swallow CJ, Girotti MJ, Rotstein OD (1991) Bacterial translocation induces procoagulant activity in tissue macrophages. A potential mechanism for end-organ dysfunction. Arch Surg 126:586–590PubMedCrossRefGoogle Scholar
  76. 76.
    Jones WG, Barber AE, Minei JP, Fahey TJ, Shires GT III, Shires GT (1990) Antibiotic prophylaxis diminishes bacterial translocation but not mortality in experimental burn wound sepsis. J Trauma 30:737–740PubMedCrossRefGoogle Scholar
  77. 77.
    Goris RJA, van Bebber EPT, Mollen RMH, Koopman JP (1991) Does selective decontamination of the gastrointestinal tract prevent multiple organ failure? Arch Surg 126:561–565PubMedCrossRefGoogle Scholar
  78. 78.
    Alexander JW, Gianotti L, Pyles T, Carey MA, Babcock GF (1991) Distribution and survival of Escherichia coli translocating from the intestine after thermal injury. Ann Surg 213:558–567PubMedCrossRefGoogle Scholar
  79. 79.
    Berczi I, Bertok L, Baindtner K, Vere B (1968) Failure of oral Escherichia coli endotoxin to induce either specific tolerance or toxic symptoms in rats. J Pathol Bact 96:481–486CrossRefGoogle Scholar
  80. 80.
    Gans H, Matsumoto M (1974) The escape of endotoxin from the intestine. Surg Gynecol Ob-stet 139:395–402Google Scholar
  81. 81.
    Rush BF, Sori AJ, Murphy TF, Smith S, Flanagan JJ Jr, Machiedo GW (1988) Endotoxemia and bacteremia during hemorrhagic shock. Ann Surg 207:549–554PubMedCrossRefGoogle Scholar
  82. 82.
    Roscher R, Oettinger W, Beger HG (1988) Bacterial microflora, endogenous endotoxin, and prostaglandins in small bowel obstruction. Am J Surg 155:348–355PubMedCrossRefGoogle Scholar
  83. 83.
    Winchurch RA, Thupari JN, Munster AM (1987) Endotoxemia in burn patients: Levels of circulating endotoxins are related to burn size. Surgery 102:808–812PubMedGoogle Scholar
  84. 84.
    Wellman W, Fink PC, Benner F, Schmidt FW (1986) Endotoxaemia in active Crohn’s disease. Treatment with whole gut irrigation and 5-aminosalicyclic acid. Gut 27:814–820CrossRefGoogle Scholar
  85. 85.
    Cuevas P, Fine J (1972) Route of absorption of endotoxin from the intestine in nonseptic shock. J Reticuloendothelial Soc 11:536–538Google Scholar
  86. 86.
    Jacob AI, Goldberg PK, Bloom N, Degenshein GA, Kozinn PJ (1977) Endotoxin and bacteria in portal blood. Gastroenterology 72:1268–1270PubMedGoogle Scholar
  87. 87.
    Prytz H, Holst-Christensen J, Korner B, Liehr H (1976) Portal venous and systemic endotoxemia in patients without liver disease and systemic endotoxemia in patients with cirrhosis. Scand J Gastroenterol 11:857–863PubMedGoogle Scholar
  88. 88.
    Moore FA, Moore EE, Poggetti R, et al. (1991) Gut bacterial translocation via the portal vein: A clinical perspective with major torso trauma. J Trauma 31:629–638PubMedCrossRefGoogle Scholar
  89. 89.
    Brearly S, Harris RI, Stone PCW, Keighly MRB (1985) Endotoxin level in portal and systemic blood. Dig Surg 2:70–72CrossRefGoogle Scholar
  90. 90.
    Bienenstock J, Ernst PB, Underdown BJ (1987) The gastrointestinal tract as an immunologic organ: State of the art. Ann Allergy 59:17–20PubMedGoogle Scholar
  91. 91.
    Elson CO, Kagnoff MF, Fiocchi C, Befus AD, Targan S (1986) Intestinal immunity and inflammation: Recent progress. Gastroenterology 91:746–768PubMedGoogle Scholar
  92. 92.
    Bonneville M, Janeway CA, Ito K, et al. (1988) Intestinal intraepithelial lymphocytes are a distinct set of gamma/delta T cells. Nature 336:479–481PubMedCrossRefGoogle Scholar
  93. 93.
    Groh V, Porcelli S, Fabbi M, et al. (1989). Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med 169:1277–1294PubMedCrossRefGoogle Scholar
  94. 94.
    Pirzer UC, Schurmann G, Post S, Betzler M, Meuer SC (1990) Differential responsiveness to CD3-Ti vs. CD2-dependent activation of human intestinal T lymphocytes. Eur J Immunol 20:2339–2342PubMedCrossRefGoogle Scholar
  95. 95.
    James SP, Kwan WC, Sneller MC (1990) T cells in inductive and effector compartments of the intestinal mucosal immune system of nonhuman primates differ in lymphokine mRNA expression, lymphokine utilization, and regulatory function. J Immunol 144:1251–1256PubMedGoogle Scholar
  96. 96.
    Taguchi T, Aicher WK, Fujihashi K, et al. (1991) Novel function for intestinal intraepithelial lymphocytes. Murine CD3+, gamma/delta TCR+ T cells produce IFN-gamma and IL-5. J Immunol 147:3736–3744PubMedGoogle Scholar
  97. 97.
    Kawanishi H, Kiely J (1988) In vitro induction of a contrasuppressor immunoregulatory network by polyclonally activated T cells derived from murine Peyer’s patches. Immunology 63:415–421PubMedGoogle Scholar
  98. 98.
    MacDonald TT, Dillon SB (1988) Chemical mediators of cellular communication. In: Hey-worth MF, Jones AL (Eds) Immunology of the Gastrointestinal Tract and Liver, Raven Press Ltd., New YorkGoogle Scholar
  99. 99.
    Deem RL, Shanahan F, Targan SR (1991) Triggered human mucosal T cells release tumor necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells. Clin Exp Immunol 83:79–84PubMedCrossRefGoogle Scholar
  100. 100.
    MacDonald TT, Hutchings P, Choy M-Y, Murch S, Cooke A (1990) Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 81:301–305PubMedCrossRefGoogle Scholar
  101. 101.
    Mowat AMCI (1989) Antibodies to IFN-prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 68:18–23PubMedGoogle Scholar
  102. 102.
    Pullman WE, Elsbury S, Kobayashi M, Hapel AJ, Doe WF (1992) Enhanced mucosal cyto-kine production in inflammatory bowel disease. Gastroenterology 102:529–537PubMedGoogle Scholar
  103. 103.
    Keshav S, Lawson L, Chung LP, Stein M, Perry VH, Gordon S (1990) Tumor necrosis factor mRNA localized to Paneth cells of normal murine intestinal epithelium by in situ hybridization. J Exp Med 171:327–332PubMedCrossRefGoogle Scholar
  104. 104.
    Bissonette EY, Befus AD (1990) Inhibition of mast cell-mediated cytotoxicity by IFN-al-pha/beta and gamma. J Immunol 145:3385–3390Google Scholar
  105. 105.
    Elitsur Y, Luk DG (1991) Beta-casomorphin (BCM) and human colonic lamina propria lymphocyte proliferation. Clin Exp Immunoll 85:493–497CrossRefGoogle Scholar
  106. 106.
    Pepys MB, Baltz ML (1983) Acute phase proteins with special reference to C reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 34:141–212PubMedCrossRefGoogle Scholar
  107. 107.
    Vetter ML, Gewürz H, Hansen B, James K, Baum LL (1983) Effects of C-reactive protein on human lymphocyte responsiveness. J Immunol 130:2121–2126PubMedGoogle Scholar
  108. 108.
    Arora PK, Miller HC (1978) Alpha 1 antitrypsin is an effector of immunological stasis. Nature 274:589–590PubMedCrossRefGoogle Scholar
  109. 109.
    Munford RS, Andersen JM, Dietschy JM (1981) Site of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes. Studies in the rat and squirrel monkey. J Clin Invest 68:1503–1513.PubMedCrossRefGoogle Scholar
  110. 110.
    Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H (1987) Interferon B-2/B cell stimulating factor type 2 shares identity with monocyte-derived hepatocyte stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci 84:7251–7255PubMedCrossRefGoogle Scholar
  111. 111.
    Decker K (1990) Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 192:245–261PubMedCrossRefGoogle Scholar
  112. 112.
    Marshall JC, Bryden K, Murdoch J (1992) The Gut-liver axis in multiple organ failure: Kupffer cell modulation of systemic immune responses. In: Matuschak GM (ed) Multiple Systems Organ Failure: Hepatic Regulation of Systemic Host Defense. Marcel Dekker Inc, New York, (in press)Google Scholar
  113. 113.
    Callery MP, Mangino MJ, Kamei T, Flye MW (1990) Interleukin-6 production by endoto-xin-stimulated Kupffer cells is regulated by prostaglandin E2. J Surg Res 48:523–527PubMedCrossRefGoogle Scholar
  114. 114.
    Keller GA, West MA, Cerra FB (1985) Macrophage-mediated modulation of hepatic function in multiple-system failure. J Surg Res 39:555–563PubMedCrossRefGoogle Scholar
  115. 115.
    Curran RD, Billiar TR, Stuehr DJ, Hofmann K, Simmons RL (1989) Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 170:1769–1774PubMedCrossRefGoogle Scholar
  116. 116.
    Colletti LM, Remick DG, Burtch DG, Kunkel SL, Strieter RM, Campbell DA (1990) Role of tumor necrosis factor alpha in the pathophysiologic alterations after hepatic ischemia/re-perfusion injury in the rat. J Clin Invest 85:1936–1943PubMedCrossRefGoogle Scholar
  117. 117.
    Fong Y, Marano MA, Moldawer LL, et al. (1990) The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 85:1896–1904PubMedCrossRefGoogle Scholar
  118. 118.
    Chisari FV, Nakamura M, Milich DR, Han K, Molden D, Leroux-Roels GG (1985) Production of two distinct and independent hepatic immunoregulatory molecules by the perfused rat liver. Hepatology 5:735–743PubMedCrossRefGoogle Scholar
  119. 119.
    Baumgardner GL, Billiar T, So SK, et al. (1989) In vitro immunosuppressive effects of mu-rine hepatocyte cytosol. Transplantation Proc 21:1154–1155Google Scholar
  120. 120.
    Thomas HC (1977) The immune response in hepatic cirrhosis: Animal and human studies. Proc Roy Soc Med 70:521–525PubMedGoogle Scholar
  121. 121.
    Cantor HM, Dumont AE (1967) Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 215:744–745PubMedCrossRefGoogle Scholar
  122. 122.
    Callery MP, Kamei T, Flye MW (1989) The effect of portacaval shunt on delayed-hyper-sensitivity responses following antigen feeding. J Surg Res 46:391–394PubMedCrossRefGoogle Scholar
  123. 123.
    Boeckx W, Sobis H, Lacquet A, Gruwez J, Vandeputte M (1975) Prolongation of allogeneic heart graft survival in the rat after implantation on portal vein. Transplantation 19:145–149PubMedCrossRefGoogle Scholar
  124. 124.
    Fujiwara H, Qian J-H, Satoh S, Kokudo S, Ikegami R, Hamaoka T (1986) Studies on the induction of tolerance to alloantigens. H. The generation of serum factor(s) able to transfer al-loantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells. J Immunol 136:2763–2768PubMedGoogle Scholar
  125. 125.
    Christou NV (1985) Host defence mechanisms in surgical patients: A correlative study of the delayed hypersensitivity skin-test response, granulocyte function and sepsis. Can J Surg 28:39–49PubMedGoogle Scholar
  126. 126.
    Keane RM, Birmingham W, Shatney CM, Winchurch RA, Munster AM (1983) Prediction of sepsis in the multitraumatic patient by assays of lymphocyte responsiveness. Surg Gyne-col Obstet 156:163–167Google Scholar
  127. 127.
    Marshall JC, Christou NV, Meakins JL (1988) Immunomodulation by altered gastrointestinal tract flora. The effects of orally administered, killed Staphylococcus epidermidis, Candida, and Pseudomonas on systemic immune responses. Arch Surg 123:1465–1469PubMedCrossRefGoogle Scholar
  128. 128.
    Marshall JC, Lee C, Meakins JL, Michel RP, Christou NV (1987) Kupffer cell modulation of the systemic immune response. Arch Surg 122:191–196PubMedCrossRefGoogle Scholar
  129. 129.
    Marshall JC, Rode H, Christou NV, Meakins JL (1988) In vivo activation of Kupffer cells by endotoxin causes suppression of nonspecific, but not specific, systemic immunity. Surg Forum 39: 111–113Google Scholar
  130. 130.
    Marshall JC, Ribeiro MA, Chu PTY, Sheiner PA, Rotstein OD (1992) Portal endotoxemia triggers the release of an immunosuppressive factor from splenic and alveolar macrophages. J Sung Res (in press)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • J. C. Marshall

There are no affiliations available

Personalised recommendations